Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xialiqi capsule for type III prostatitis
ChiCTR2200057101Phase 4Not yet recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Mar 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Xialiqi in Prostatodynia (CP/CPPS) (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: NIH-CPSI score. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
Xialiqi
03
Conditions
Prostatodynia (CP/CPPS)
Beyond the preview
Go deeper on ChiCTR2200057101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057101.